Search Results < Internal Medicine

38 results

Rate Search Results

News
Burg co-edits special issue in Health Psychology
Matthew M. Burg, PhD, professor at the Yale School of Medicine and clinical psychologist, co-edited a special issue in the journal Health Psychology.
19 Sep 2022
News
Uncovering New Approaches to a Common Inherited Heart Disorder
Research led by Muhammad Riaz, PhD, Jinkyu Park, PhD, and Lorenzo Sewanan, MD, PhD, provides a mechanism to identify abnormalities linked with hypertrophic cardiomyopathy.
27 Jul 2022
News
Cognitive behavioral therapy for insomnia improves function in people with heart failure, Yale study finds
Insomnia is common in people with chronic heart failure (HF), affecting up to 75% of patients
7 Dec 2021
News
Countdown to 2021 American Heart Association Scientific Sessions
Preparations are underway for the American Heart Association Scientific Sessions on November 13-15.
16 Aug 2021
News
What's New in Hypertrophic Cardiomyopathy, With Gregory Weiss, MD
Hypertrophic cardiomyopathy or HCM is one of the most common genetic or congenital cardiac diseases.
Source: Practical Cardiology
5 Aug 2021
News
Mavacamten-Induced Cardiac Remodeling in HCM
HCM is a complex myocardial disorder with variegated genetic underpinnings with an apparent common pathobiology defined by enhanced cardiac actin-myosin interactions with resultant hypercontractility at the level of the cardiac sarcomere.
Source: American College of Cardiology
28 Jun 2021
News
House of Cards Journal Club presents: EXPLORER-HCM
The House of Cards Journal Club hosted a discussion with Daniel Jacoby, MD, on the EXPLORER-HCM trial.
23 Jun 2021
News
Discoveries & Impact (June 2021)
Discoveries & Impact (June 2021)
16 Jun 2021
News
Mavacamten Is Effective in Treating Obstructive Hypertrophic Cardiomyopathy
A new analysis of the EXPLORER-HCM study evaluating mavacamten, an investigational, first-in-class cardiac myosin inhibitor, in patients with obstructive hypertrophic cardiomyopathy (oHCM), found at 30 weeks improvement in the Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ OSS) was greater in mavacamten patients than placebo.
Source: DAIC
15 May 2021
News
Hypertrophic Cardiomyopathy (HCM) Webinar on May 20
Register to attend a webinar with Daniel L. Jacoby, MD, Arnar Geirsson, MD, and Rachel Lampert, MD. Northeast Medical Group cardiologists Alon Ronen, MD, and Adam Schussheim, MD, join the discussion.
12 May 2021
News
Heart Rhythm Society’s Online Hypertrophic Cardiomyopathy Course Now Available
A distance-learning course on hypertrophic cardiomyopathy (HCM) is now available on Heart Rhythm 365 for free.
25 Mar 2021
News
Strategies to accelerate diagnosis and treatment of rare cardiovascular diseases
The current landscape for patients with rare cardiovascular disease has shifted. Using genome sequencing Yale physician-scientists have begun to elucidate the pathophysiology of genetic disorders and develop treatment guidelines and recommendations.
25 Feb 2021
News
The 25 Best Ways to Protect Your Heart Now
Take advantage of new tech, new science, and new thinking.
Source: Men's Health
14 Feb 2021
News
Meet the 2020 Cardiovascular Medicine Pitch Competition Contestants
This two-part virtual series will be held on Dec. 1 and Dec. 8 at 8:00 a.m. EST via Zoom.
22 Nov 2020
News
Enter the YSM/YNHH Cardiovascular Medicine Grand Rounds Pitchfest
Yale New Haven Hospital’s Heart and Vascular Center and the Section of Cardiovascular Medicine are scanning the Yale community for the most promising innovators. Submit an online proposal by November 16 for an opportunity to win $7,000.
24 Sep 2020
News
Yale Succeeds With a More Inclusive Approach to Heart Transplants
Doctors at Yale New Haven Hospital used a more aggressive selection process to more than quadruple the number of heart transplants performed there while maintaining positive patient outcomes, according to a new study.
18 Sep 2020
News
Trial supports first specific treatment for obstructive hypertrophic cardiomyopathy
Mavacamten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy, according to results of the EXPLORER-HCM trial presented in a Hot Line session today at ESC Congress 2020.
Source: Medical Xpress
31 Aug 2020
News
ESC: MyoKardia's mavacamten boosts heart function in phase 3, teeing up 2021 filing
Explorer-HCM, showed statistically significant improvements in heart function and oxygen consumption after 30 weeks with the heart therapy mavacamten.
Source: FierceBiotec
29 Aug 2020
News
Study: COVID causes more 'broken hearts'
Researchers found there has been a higher incidence of a stress induced heart condition that mimics a heart attack during the pandemic.
Source: Connecticut Post
14 Jul 2020
News
Organ Donation: Giving and Receiving Life
Research at the Yale School of Medicine could improve the odds of receiving an organ transplant.
Source: WTNH
24 Feb 2020